Literature DB >> 33054575

Autophagy unleashes noncanonical microRNA functions.

Donato Santovito1,2,3, Virginia Egea1, Kiril Bidzhekov1, Lucia Natarelli1,2, André Mourão4, Xavier Blanchet1, Kanin Wichapong5, Maria Aslani1,2, Coy Brunßen6, Michael Horckmans7, Michael Hristov1, Arie Geerlof4, Esther Lutgens1,2,8, Mat J A P Daemen8, Tilman Hackeng5, Christian Ries1, Triantafyllos Chavakis9, Henning Morawietz6, Ronald Naumann10, Philipp Von Hundelshausen1,2, Sabine Steffens1,2, Johan Duchêne1, Remco T A Megens1,5, Michael Sattler4,11, Christian Weber1,2,5,12.   

Abstract

MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression which act by guiding AGO (argonaute) proteins to target RNA transcripts in the RNA-induced silencing complex (RISC). This macromolecular complex includes multiple additional components (e.g., TNRC6A) that allow for interaction with enzymes mediating inhibition of translation or RNA decay. However, miRNAs also reside in low-molecular weight complexes without being engaged in target repression, and their function in this context is largely unknown. Our recent findings show that endothelial cells exposed to protective high-shear stress or MTORC inhibition activate the macroautophagy/autophagy machinery to sustain viability by promoting differential trafficking of MIR126 strands and by enabling unconventional features of MIR126-5p. Whereas MIR126-3p is degraded upon autophagy activation, MIR126-5p interacts with the RNA-binding protein MEX3A to form a ternary complex with AGO2. This complex forms on the autophagosomal surface and facilitates its nuclear localization. Once in the nucleus, MIR126-5p dissociates from AGO2 and establishes aptamer-like interactions with the effector CASP3 (caspase 3). The binding to MIR126-5p prevents dimerization and proper active site formation of CASP3, thus inhibiting proteolytic activity and limiting apoptosis. Disrupting this pathway in vivo by genetic deletion of Mex3a or by specific deficiency of endothelial autophagy aggravates endothelial apoptosis and exacerbates the progression of atherosclerosis. The direct inhibition of CASP3 by MIR126-5p reveals a non-canonical mechanism by which miRNAs can modulate protein function and mediate the autophagy-apoptosis crosstalk.

Entities:  

Keywords:  Atherosclerosis; Autophagy; Endothelial cells; MEX3A; Noncanonical miRNA functions; miR-126-5p; microRNA

Mesh:

Substances:

Year:  2020        PMID: 33054575      PMCID: PMC7751630          DOI: 10.1080/15548627.2020.1830523

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis.

Authors:  Donato Santovito; Virginia Egea; Kiril Bidzhekov; Lucia Natarelli; André Mourão; Xavier Blanchet; Kanin Wichapong; Maria Aslani; Coy Brunßen; Michael Horckmans; Michael Hristov; Arie Geerlof; Esther Lutgens; Mat J A P Daemen; Tilman Hackeng; Christian Ries; Triantafyllos Chavakis; Henning Morawietz; Ronald Naumann; Philipp von Hundelshausen; Sabine Steffens; Johan Duchêne; Remco T A Megens; Michael Sattler; Christian Weber
Journal:  Sci Transl Med       Date:  2020-06-03       Impact factor: 17.956

  1 in total
  3 in total

Review 1.  Role of autophagy and transcriptome regulation in acute brain injury.

Authors:  Vijay Arruri; Raghu Vemuganti
Journal:  Exp Neurol       Date:  2022-03-05       Impact factor: 5.620

2.  hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP.

Authors:  Jian Liang; Xing Li; Jian Xu; Guang-Mou Cai; Jian-Xuan Cao; Bo Zhang
Journal:  Aging (Albany NY)       Date:  2021-12-12       Impact factor: 5.682

Review 3.  Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician.

Authors:  Salvatore De Rosa; Claudio Iaconetti; Ceren Eyileten; Masakazu Yasuda; Michele Albanese; Alberto Polimeni; Jolanda Sabatino; Sabato Sorrentino; Marek Postula; Ciro Indolfi
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.